| A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology MJ Herrgĺrd, N Swainston, P Dobson, WB Dunn, KY Arga, M Arvas, ... Nature biotechnology 26 (10), 1155-1160, 2008 | 661 | 2008 |
| The role of protein interaction networks in systems biomedicine T Sevimoglu, KY Arga Computational and structural biotechnology journal 11 (18), 22-27, 2014 | 146 | 2014 |
| Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis M Kori, B Aydın, S Unal, KY Arga, D Kazan Omics: a journal of integrative biology 20 (11), 645-661, 2016 | 124 | 2016 |
| Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective M Kori, K Yalcin Arga PLoS One 13 (7), e0200717, 2018 | 100 | 2018 |
| Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s disease MR Rahman, T Islam, B Turanli, T Zaman, HM Faruquee, MM Rahman, ... Computational biology and chemistry 78, 431-439, 2019 | 94 | 2019 |
| Effective stimulating factors for microbial levan production by Halomonas smyrnensis AAD6T HK Sarilmiser, O Ates, G Ozdemir, KY Arga, ET Oner Journal of Bioscience and Bioengineering 119 (4), 455-463, 2015 | 94 | 2015 |
| Tissue-specific molecular biomarker signatures of type 2 diabetes: an integrative analysis of transcriptomics and protein–protein interaction data B Calimlioglu, K Karagoz, T Sevimoglu, E Kilic, E Gov, KY Arga Omics: a journal of integrative biology 19 (9), 563-573, 2015 | 79 | 2015 |
| Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways K Karagoz, R Sinha, KY Arga Omics: a journal of integrative biology 19 (2), 115-130, 2015 | 79 | 2015 |
| Drug repositioning for effective prostate cancer treatment B Turanli, M Grřtli, J Boren, J Nielsen, M Uhlen, KY Arga, A Mardinoglu Frontiers in physiology, 500, 2018 | 78 | 2018 |
| Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer E Gov, KY Arga Scientific reports 7 (1), 4996, 2017 | 76 | 2017 |
| Genome-scale reconstruction of metabolic network for a halophilic extremophile, Chromohalobacter salexigens DSM 3043 Ö Ates, ET Oner, KY Arga BMC systems biology 5, 1-13, 2011 | 72 | 2011 |
| Identification of prognostic biomarker signatures and candidate drugs in colorectal cancer: insights from systems biology analysis MR Rahman, T Islam, E Gov, B Turanli, G Gulfidan, M Shahjaman, ... Medicina 55 (1), 20, 2019 | 67 | 2019 |
| Systems biology based drug repositioning for development of cancer therapy B Turanli, O Altay, J Borén, H Turkez, J Nielsen, M Uhlen, KY Arga, ... Seminars in cancer biology 68, 47-58, 2021 | 64 | 2021 |
| Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning B Turanli, C Zhang, W Kim, R Benfeitas, M Uhlen, KY Arga, A Mardinoglu EBioMedicine 42, 386-396, 2019 | 62 | 2019 |
| Molecular signatures of ovarian diseases: Insights from network medicine perspective M Kori, E Gov, KY Arga Systems biology in reproductive medicine 62 (4), 266-282, 2016 | 62 | 2016 |
| Drug targeting and biomarkers in head and neck cancers: insights from systems biology analyses T Islam, R Rahman, E Gov, B Turanli, G Gulfidan, A Haque, KY Arga, ... Omics: a journal of integrative biology 22 (6), 422-436, 2018 | 58 | 2018 |
| Multiomics analysis of tumor microenvironment reveals Gata2 and miRNA-124-3p as potential novel biomarkers in ovarian cancer E Gov, M Kori, KY Arga Omics: a journal of integrative biology 21 (10), 603-615, 2017 | 56 | 2017 |
| A network-based cancer drug discovery: from integrated multi-omics approaches to precision medicine B Turanli, K Karagoz, G Gulfidan, R Sinha, A Mardinoglu, KY Arga Current pharmaceutical design 24 (32), 3778-3790, 2018 | 46 | 2018 |
| The stimulatory effect of mannitol on levan biosynthesis: Lessons from metabolic systems analysis of Halomonas smyrnensis AAD6T O Ates, KY Arga, ET Oner Biotechnology progress 29 (6), 1386-1397, 2013 | 43 | 2013 |
| Multi-omic data interpretation to repurpose subtype specific drug candidates for breast cancer B Turanli, K Karagoz, G Bidkhori, R Sinha, ML Gatza, M Uhlen, ... Frontiers in genetics 10, 420, 2019 | 41 | 2019 |
Beste Calimlioglu TuranliMarmara UniversityVerified email at marmara.edu.tr
